Ribophorin II Overexpression Is Associated with Poor Response to Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in P16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma

This study aims to evaluate the relationship between human ribophorin II (RPN2) and the effect of treatment using induction therapy with docetaxel, cisplatin, and fluorouracil (TPF) for p-16 negative locally advanced head and neck squamous cell carcinoma (HNSCC). A total of 203 patients with locally...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei-Shan, Luo, Sheng-Dean, Chiu, Tai-Jan, Wang, Yu-Ming, Chen, Wei-Chih, Chien, Chih-Yen, Fang, Fu-Min, Huang, Tai-Lin, Li, Shau-Hsuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464953/
https://www.ncbi.nlm.nih.gov/pubmed/34575229
http://dx.doi.org/10.3390/jcm10184118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464953/
https://www.ncbi.nlm.nih.gov/pubmed/34575229
http://dx.doi.org/10.3390/jcm10184118

Ejemplares similares